Search results for Hanmi Pharmaceutical
AI & Enterprise
Should AI model development really be slowed? AI safety debate enters new phase
The debate over AI model safety has flared again as people working at, or who previously worked at, AI companies raise the prospect of human extinction from AI. Major AI companies have also floated slowing AI development. Sam Altman (샘 알트먼), CEO of OpenAI, said solving AI safety issues comes first and said the company will not pursue an IPO this year.
AI & Enterprise
MegazoneCloud to build Hanmi Pharm quality assurance AI agent using AIR Studio
MegazoneCloud said on Sept. 7 it will build an AI agent to automate quality assurance work at Hanmi Pharmaceutical, based on its enterprise AI OS, AIR Studio. The project is being carried out under the AX One-Stop Voucher Support Program run by the Ministry of Science and ICT and the National IT Industry Promotion Agency. The agent will search and summarise more than 4,000 quality documents and compare them with the latest regulations.
AI & Enterprise
Megazone to support Hanmi Science AX in AI-based work innovation partnership
Megazone, the parent company of AI and cloud firm MegazoneCloud, agreed to cooperate with Hanmi Science to strengthen the company’s overall digital innovation capabilities, it said on Sunday. Under the deal, the two sides plan to jointly pursue AX-based work innovation tasks, cooperation to enhance digital transformation capabilities and other AI and digital innovation initiatives. They also plan to form a working-level consultative body to identify projects and review execution plans.
